A BCR-ABL(p190) fusion gene made by homologous recombination causes B- cell acute lymphoblastic leukemias in chimeric mice with independence of the endogenous bcr product

Blood

Volumn 90, Issue 6, 1997, Pages 2168-2174

  Castellanos, A ^b   Pintado, B ^b   Weruaga, E ^b   Arevalo R ^b   Lopez A ^b   Orfao, A ^b   Sanchez Garcia I ^a  

^a Instituto de Biología Funcional y Genómica and Departamento de Microbiología y Genética   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; GENE PRODUCT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL LEUKEMIA; CHIMERA; CHROMOSOME 22; CHROMOSOME 9; CONTROLLED STUDY; EMBRYO; FEMALE; GENE FUSION; GENETIC RECOMBINATION; HEMATOPOIETIC STEM CELL; LEUKEMOGENESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECIPROCAL CHROMOSOME TRANSLOCATION;

EID: 0030752777     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.6.2168.2168_2168_2174     Document Type: Article

References (43)

1. Clark SS, McLaughlin J, Crist WM, Champlin R, Witte ON: Unique forms of the abl tyrosine kinase distinguish Ph'-positive CML from Ph'-positive ALL. Science 235:85, 1987
2. Daley CG, McLaughlin J, Witte ON, Baltimore D: The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/ 3T3 fibroblasts. Science 237:532, 1987
3. Elefanty AG, Hariharan IK, Cory S: bcr-abl, the hallmark of chronic myeloid leukemia in man, induces multiple haematopoietic neoplasms in mouse EMBO J 9:1068, 1990
4. Gishizky ML, Johnson-White J, Witte ON: Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice. Proc Natl Acad Sci USA 90:3755, 1993
5. Heisterkamp N, Jenster G, Hoeve HT, Zovich D, Pattengale PK, Groffen J: Acute leukemia in bcr/abl transgenic mice. Nature 344:251, 1990
6. Voncken JW, Morris C, Pattengale P, Dennert G, Kikly C, Groffen J, Heisterkamp N: Clonal development and karyotype evolution during leukemogenesis of BCR/ABL transgenic mice. Blood 79:1029, 1992
7. Griffiths SD, Healy LE, Ford AM, Bennett CA, Voncken JW, Heisterkamp N, Groffen J, Greaves MF: Clonal characteristics of acute lymphoblastic cells derived from bcr/abl p190 transgenic mice. Oncogene 7:1391, 1992
8. Voncken JW, Griffiths S, Greaves MF, Pattengale PK, Heisterkamp N, Groffen J: Restricted oncogenicity of BCR/ABL P190 in transgenic mice. Cancer Res 52:4534, 1992
9. Hermans A, Heisterkamp N, von Lindern M, van Baal S, Meijer D, van der Plas D, Wiedermann LM, Groffen J, Bootsma D, Grosveld G: Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia. Cell 51:33, 1987
10. Kelliher MA, McLaughlin J, Witte ON, Rosenberg N: Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR-ABL. Proc Natl Acad Sci USA 87:6649, 1990
11. Konopka JB, Watanabe SM, Witte ON: An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 37:1035, 1984
12. Mes-Masson A-M, McLaughlin J, Daley GQ, Paskind M, Witte ON: Overlapping cDNA clones define the complete coding region for the P210 c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome. Proc Natl Acad Sci USA 83:9768, 1986
13. Shtivelman E, Lifshitz B, Gale RP, Canaani E: Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 315:550, 1985
14. Rowley JD: A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290, 1973
15. Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G: Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36:93, 1984
16. Grosvelt G, Verwoerd T, van Agthoven T, de Klein A, Ramachandran KL, Heisterkamp N, Stam K, Groffen J: The chronic myelocytic cell line K562 contains a breakpoint in bcr and produces a chimeric bcr/c-abl transcript. Mol Cell Biol 6:607, 1986
17. Kurzrock R, Shtalrid M, Rommero P, Kloetzer WS, Talpas M, Trujillo JM, Blick M, Beran M, Gutterman JU: A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia. Nature 325:631, 1987
18. Dhut S, Chaplin T, Young BD: Normal c-abl gene protein: A nuclear component. Oncogene 6:1459, 1991
19. Lugo TG, Pendergast AM, Muller AJ, Witte ON: Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 247:1079, 1990
20. Mc Whirter JR, Wang JYJ: Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins. Mol Cell Biol 11:1553, 1991
21. McLaughlin J, Chianese E, Witte ON: Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells. Mol Cell Biol 9:1866, 1989
22. Chan LC, Karhi KK, Rayter SI, Heisterkamp N, Eridani S, Powles R, Lawler SD, Groffen J, Foulkes JG, Greaves MF, Wiedemann LM: A novel abl protein expressed in Philadelphia chromosome-positive acute lymphoblastic leukemia. Nature 325:635, 1987
23. Walker LC, Ganesan TS, Dhut S, Gibbonas B, Lister TA, Rothbard J, Young BD: Novel chimaeric protein expressed in Philadelphia-positive acute lymphoblastic leukaemia. Nature 329:851, 1987
24. Clark SS, Chen E, Fizzotti M, Witte ON, Malkovska V: BCR-ABL and v-abl oncogenes induce distinct patterns of thymic lymphoma involving different lymphocyte subsets. J Virol 67:6033, 1993
25. bcr-abl gene of the Philadelphia chromosome. Science 247:824, 1990
26. Hariharan IK, Harris AW, Crawford M, Abud H, Webb E, Cory S, Adams JM: A bcr-v-abl oncogene induces lymphomas in transgenic mice. Mol Cell Biol 9:2798, 1989
27. bcr-abl by metallothionein promoter induced T-cell leukemia in transgenic mice. Blood 85:2853, 1995
28. Corral J, Lavenir I, Impey H, Warren AJ, Forster A, Larson TA, Bell S, Mckenzie ANJ, King G, Rabbitts TH: An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: A method to create fusion oncogenes. Cell 85:853, 1996
29. Liu J, Campbell M, Guo JQ, Lu D, Xian YM, Andersson BS, Arlinghaus RB: BCR-ABL tyrosine kinase is autophosphorylated or trans-phosphorylates P160 BCR on tyrosine predominantly within the first BCR exon. Oncogene 8:101, 1993
30. Lu D, Liu J, Campbell M, Guo JQ, Heisterkamp N, Groffen J, Canaani E, Arlinghaus RB: Tyrosine phosphorylation of P160 BCR by P210 BCR-ABL. Blood 82:1257, 1993
31. Voncken JW, van Schaick H, Kaartinen V, Deemer K, Coates T, Landing B, Pattengale P, Dorseuil O, Bokoch GM, Groffen J, Heisterkamp N: Increased neutrophil respiratory burst in bcr-null mutants. Cell 80:719, 1995
32. Robertson EJ: Teratocarcinomas and Embryonic Stem Cells: A Practical Approach. Oxford, UK, IRL, 1987
33. Harlow E, Lane D: Antibodies: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1988, p 473
34. Ahn M-J, Nason-Burchenal K, Moasser MM, Duritrovsky E: Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RARα or PML. Oncogene 10:2307, 1995
35. Maru Y, Witte ON: The BCR gene encodes a novel serine/ threonine kinase activity within a single exon. Cell 67:459, 1991
36. Muller AJ, Young JC, Pendergast AM, Pondel M, Landau NR, Littman DR, Witte ON: BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol Cell Biol 11:1785, 1991
37. Palacios R, Karasuyama H, Rolink A: Ly1 + POR-B lymphocite clones: Phenotype, growth requirements and differentiation in vitro and in vivo. EMBO J 6:3687, 1987
38. Hardy RR, Carmack CE, Shinton SA, Kemp JD, Hayakawa K: Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med 173:1213, 1991
39. Ford AM, Molgaard HV, Greaves MF, Gould HJ: Immunoglobulin gene organization and expression in hematopoietic stem cell leukemia. EMBO J 2:997, 1983
40. Sánchez-García I, Grütz G: Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL-2. Proc Natl Acad Sci USA 92:5287, 1995
41. Sánchez-García I, Martín-Zanca D: Regulation of Bcl-2 gene expression by BCR-ABL is mediated by Ras. J Mol Biol 267:225, 1997
42. Choo Y, Sánchez-García I, Klug A: In vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequence. Nature 372:642, 1994
43. p190 cells. Mol Med 2:125,1996